港股異動 | 李寧(2331.HK)高開4.04% 第三季度同店銷售按年錄得20%-30%高段增長
格隆匯10月26日丨李寧(2331.HK)高開4.04%,報95.25港元,暫成交1億港元,最新市值2377億港元。李寧昨日盤後披露2021年第三季度最新運營狀況,同店銷售方面,以去年同季度伊始已投入運營的李寧銷售點計算(不包括李寧YOUNG),截至2021年9月30日止第三季度,整個平台的同店銷售按年錄得20%-30%高段增長。就渠道而言,零售(直接經營)渠道錄得30%-40%低段增長及批發(特許經銷商)渠道錄得20%-30%中段增長,電子商務虛擬店鋪業務按年增長為30%-40%中段增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.